Gauthier and colleagues evaluated concomitant ibrutinib and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in a study of patients with chronic ly
AbstractPrimary cardiac tumors are a rare disease, with 20% of the cases being malignant. Among them, angiosarcoma is characterized by a short clinical course and…
The standard strategy for TLS mitigation is dose escalation and TLS monitoring during dose ramp-up, and there is an ongoing debate on whether the standard…
In this issue of Blood, Comazzetto et al1 demonstrate that vitamin C deprivation promotes stem cell quiescence and functionally reprograms multipotent hema
AbstractBackgroundCoronary microvascular dysfunction (CMD) is a common cause of angina with no obstructive coronary artery disease (ANOCA), and effective treatment options are limited.ObjectivesThi…
High-volume disease (HVD) and low-volume disease (LVD) definitions in metastatic hormone-sensitive prostate cancer (mHSPC) patients are based on conventional imaging (CI) (CT/MRI with bone scan…
Key PointsLower-intensity CPX-351 plus venetoclax was tolerated as induction therapy in adults with poor-risk AML unfit for intense chemotherapy.Combinatio
Sidana et al1 report on their real-world experience (RWE) of the use of ciltacabtagene autoleucel (cilta-cel) for patients with relapsed myeloma with the g
The combination in a phase II trial produced high complete response rates in patients with newly diagnosed AML.
AbstractBackgroundInfluenza virus may cause severe infection in patients with heart failure. It is known that influenza infection is associated with increased morbidity and mortality in…
Researchers studied outcomes of transplant recipients who received kidneys from toxoplasma-positive versus negative donors.
